The Call4Ideas of MIND Education kicks off
The Call 4 Ideas of the MIND Education program, the project that involves young people and students in the co-creation of the City of the Future, kicks off.
Submit your idea by April 29, 2022!
Conceived and promoted by Arexpo and Lendlease together with Human Technopole, IRCCS Galeazzi, Fondazione Triulza, Federated Innovation area Life Sciences & Health Care – with leading companies in the sector such as Accenture, AstraZeneca, Be Whiz, Bio4Dreams, Bracco, Life Science District, Nippon Gases cooperate Italy, Novartis, Stevanato Group, Synlab – the Call 4 Ideas invites recent graduates (who obtained their degree in the year 2021 and 2022), students and doctoral students of Italian universities to develop ideas and project on two fundamental themes of the innovation district:
1. MEANWHILE SOLUTIONS @MIND: the aim is using the “waiting time” – the period between the approval of the Masterplan and its realization – as a tool to mend social tissues and as a strategic resource to design a more sustainable and inclusive future that promotes citizen participation and well-being.
2. Health Data Science: by using digital technologies and Big Data, finding solutions that improve the health and well-being of citizens through the adoption of behaviors and lifestyles that prevent diseases, help their early diagnosis and the sharing of information (data) by the population.
A jury made up of professionals and researchers from the promoters will select the 3 best ideas for each Call that will be awarded with the following prizes:
- 1st prize € 5,000
- 2nd prize € 3,000
- 3rd prize € 2,000
In addition, the winners will have the opportunity to present their project at the final event of MIND education in June 2022.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.